National Bank Of Canada Moderna, Inc. Transaction History

National Bank Of Canada

$72.7 Billion
Q3 2024

A detailed history of National Bank Of Canada transactions in Moderna, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 235,266 shares of MRNA stock, worth $9.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

235,266

Previous 235,266 -0.0%

Holding current value

$9.27 Million

Previous $15.7 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$63.64 - $125.14 $5.77 Million - $11.4 Million	90,739 Added 62.78%	235,266 $15.7 Million
Q2 2024 Aug 02, 2024	SELL	$101.21 - $166.61 $5.15 Million - $8.48 Million	-50,897 Reduced 26.04%	144,527 $17.2 Million
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $9.81 Million - $13.3 Million	-114,956 Reduced 37.04%	195,424 $20.8 Million
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $28.1 Million - $42.2 Million	-404,181 Reduced 56.56%	310,380 $30.9 Million
Q3 2023 Oct 10, 2023	BUY	$96.41 - $126.61 $54.4 Million - $71.5 Million	564,679 Added 376.75%	714,561 $73.8 Million
Q2 2023 Jul 26, 2023	BUY	$118.5 - $160.53 $11.8 Million - $16.1 Million	99,989 Added 200.41%	149,882 $18.2 Million
Q1 2023 Apr 12, 2023	BUY	$135.66 - $197.02 $2.74 Million - $3.99 Million	20,234 Added 68.22%	49,893 $7.66 Million
Q4 2022 Jan 24, 2023	SELL	$118.38 - $210.04 $6.54 Million - $11.6 Million	-55,235 Reduced 65.06%	29,659 $0
Q3 2022 Oct 13, 2022	BUY	$118.07 - $194.18 $8.37 Million - $13.8 Million	70,864 Added 505.09%	84,894 $10 Million
Q2 2022 Jul 28, 2022	SELL	$117.13 - $176.59 $12.3 Million - $18.5 Million	-104,967 Reduced 88.21%	14,030 $2.03 Million
Q1 2022 May 05, 2022	BUY	$126.46 - $235.05 $13.7 Million - $25.4 Million	108,203 Added 1002.44%	118,997 $20.3 Million
Q4 2021 Jan 24, 2022	BUY	$225.82 - $368.51 $2.44 Million - $3.98 Million	10,794 New	10,794 $2.69 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Account

National Bank Of Canada Moderna, Inc. Transaction History